Europe Vaccine Packaging Market - Focused Insights 2023-2028

The Europe vaccine packaging market was valued at USD 1.01 billion in 2022 and is projected to reach USD 1.48 billion in 2028, with a compound annual growth rate (CAGR) of 6.55% during the study period. Europe is one of the fastest-growing markets for vaccine packaging across the globe. In Europe, the vaccine packaging market is growing gradually due to a rise in the demand for vaccines, a surge in targeted patient populations, the presence of leading key vendors, and high investment in drug development. 

MARKET DEFINITION  

Vaccine packaging is the process that includes securely packaging vaccines to keep their therapeutic potency for a certain period. Vaccine packaging comprises vials, ampoules, prefilled syringes, and bags & pouches, which is the initial level of packaging. 

MARKET DRIVERS  

Increasing Investment in Research and Development of Vaccines: The rise in the prevalence of various viral infections and immunological disorders, such as COVID-19, among the population in Europe is one of the major factors driving the growth of the vaccine packaging market. In recent years, the rapid spread of severe infections, such as SARS, Ebola, and HIV, has highlighted the need for a global preparedness for pandemics, which leads to extremely rapid development and the extensive distribution of vaccines. This forces pharmaceutical manufacturers to speed up their vaccine manufacturing process so that urgent demands can be met. Hence, packaging vaccines becomes a necessity from the moment they are manufactured until they are ultimately dispensed. Immunological diseases are amongst the leading causes of death among young and middle-aged women in Europe.  

Increasing Government Expenditure on Immunization Programs: Growing healthcare expenditure by healthcare organizations and biopharma firms in vaccine R&D and growing government expenditure in immunization programs will boost market growth. For instance, European governments sponsor numerous federal organizations and initiatives that are engaged in vaccination-related activities. They spend hundreds of millions per year on vaccination research and production to procure and administer vaccines, ensure the protection of approved vaccines, and perform educational and other promotional initiatives to assist the use of vaccines. 

EUROPE VACCINE PACKAGING MARKET INSIGHTS

• Primary packaging is growing significantly, with the fastest CAGR of 6.72% of the Europe vaccine packaging market during the forecast period. The growth of this segment can be attributed to the growing demand for vials, ampoules, and syringes with the increasing demand for vaccines. As primary packaging is the first point of contact material that envelops a vaccine product, it holds significant growth. 
• Based on primary packaging type, the vials packaging segment accounted for a major market share in the European vaccine packaging market. It dominated the other segments due to its wide usage as an essential primary packaging element for vaccine products.  
• Based on material type, the glass segment is growing with the highest CAGR in the European vaccine packaging market during the forecast period. The growth can be attributed to its external barrier properties and its highest demand in primary packaging.  
• The pharmaceutical and biotech companies accounted for the highest share of more than 46% in the U.S. vaccine packaging market, which is owing to the rise in contagious or infectious diseases, the growing aging population, the growing demand for vaccines, and innovations in vaccine development are some of the major factors driving the vaccine packaging industry.   

REGIONAL ANALYSIS  

The vaccine packaging market in Switzerland is growing significantly, with the fastest CAGR of 9.40% during the forecast period. The market is witnessing significant growth due to Switzerland being highly focused on producing and using recyclable packaging materials, creating lucrative opportunities for manufacturers of recyclable or eco-friendly vaccine packaging.  

Germany accounted for the highest revenue share of the Europe vaccine packaging market. The German market is witnessing significant growth due to a rise in non-communicable diseases, high per capita income, the presence of leading vaccine companies, and high investments in drug development. 

VENDOR LANDSCAPE  

Europe vaccine packaging market report contains exclusive data on 25 vendors. The competitive scenario in the European vaccine packaging market is intensifying with the global players offering a diverse range of products. SCHOTT, Gerresheimer AG, Stevanato Group, Amcor, SGD Pharma, WestRock, Corning Incorporation, and others are currently dominating the Europe vaccine packaging market. The major players are focusing on strategic acquisitions, licensing & collaboration agreements with emerging players to enter the vaccine packaging market and gain access to commercially launched products.